• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT, ANTIBIOTIC Back to Search Results
Catalog Number 110034355
Device Problem Improper Chemical Reaction (2952)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/28/2021
Event Type  malfunction  
Manufacturer Narrative
This is a combination product (b)(4).Event occurred in united states.The device was not returned to the manufacturer.Therefore, it could not be analyzed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No available photos have been provided by the customer which confirm the issue, but the received picture with the labels confirms the references of the two involved products.1 complaint (1 product), this one included, has been recorded on refobacin bone cement r 1x40 us, reference 110034355, batch 840cag1903 since ever.According to available data, the root cause could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It has been reported that the cement would not mix and the powder was still present.It was also reported later, that the paste had clumps so the consistency failed during the mixing process (stryker advanced mixing system).Another cement was prepared and surgery was finished.No adverse events have been reported as a result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BC R 1X40 US
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key12258918
MDR Text Key264492057
Report Number3006946279-2021-00125
Device Sequence Number1
Product Code MBB
UDI-Device Identifier00880304990197
UDI-Public0880304990197
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171540
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 08/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number110034355
Device Lot Number840CAG1903
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/31/2021
Initial Date FDA Received08/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-